HOLX News and Press, Hologic Inc. From 03/15/21

What was once a leading women's healthcare company got a boost from the pandemic due to COVID testing. Hologic (HOLX) has a leading position in many testing areas and is poised to gain from international expansion. Read more to learn why this stock belongs in your portfolio. Hologic ( ...

Glenview Capital Management’s 13F portfolio value increased from $3.19B to $4.36B this quarter. The number of positions increased from 45 to 54. They increased Lyft Inc. & Boston Scientific while reducing Meritor and Hologic during the quarter. The top three stakes are ...

After experiencing a powerful rally since last March’s market correction, growth stocks have started to see a sell-off lately. However, because pandemic-driven trends are expected to continue in the foreseeable future, some growth stocks are still worth buying to benefit from their fut...

Wall Street usually prices in events before they happen, and that is as true for Hologic (NASDAQ: HOLX) as it is for any other company.  If news is anticipated, and investors want to know what to expect, a simple review of the stock's price action is one of the best ways to do that...

New Global Women’s Health Index Conducted through Gallup’s World Poll to Benchmark State of Women’s Health in More than 115 Countries Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, today announced a collaboration with leading analyt...

The demand for medical devices is growing with increasing numbers of people being vaccinated for COVID-19 and resuming hospital visits for regular or elective surgeries. In addition to increasing hospital admittances for non-COVID-19 treatment, we believe the growing importance of healthcare ...

The following slide deck was published by Hologic, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Hologic, Inc. 2021 Q1 - Results - Earnings Call Presentation

Hologic (HOLX) has acquired Diagenode, a privately held European developer and manufacturer of molecular diagnostic assays and epigenetics products, for ~$159M.Diagenode offers more than 30 real-time PCR tests that are CE-marked to detect bacteria, parasites, and viruses involved in sexually ...

-- Transaction Expands and Diversifies Hologic’s Diagnostic Business Across Test Menu, Customer Segments and Geography – Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, announced today that it has acquired Diagenode, a privately held, European deve...

Investors often shrug off the impact of stimulus, but when fabricated demand comes into the stock market everything is affected, even Hologic (NASDAQ: HOLX) and other stocks that might not be direct beneficiaries.  They say, a rising tide lifts all boats, and multiple expansion is ...